Nosocomial Infection Caused by Methicillin-Resistant Staphylococcus Aureus in Palestine

adwank's picture
Journal Title, Volume, Page: 
Microb Drug Resist. 2005 Spring;11(1):75-7.
Year of Publication: 
2005
Authors: 
Adwan K.
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Current Affiliation: 
Department of Biology, Faculty of Science, An-Najah National University, Nablus. Palestine
Abu-Hasan N.
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Adwan G.
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Jarrar N.
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Abu-Shanab B.
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Abu-Zant A.
Department of Biological Sciences, An-Najah N. University, Nablus, Palestine
Preferred Abstract (Original): 

This report presents the prevalence of Palestinian isolates of methicillin-resistant Staphylococcus aureus (MRSA) in nosocomial infections and their antibiotic resistant pattern. A total of 321 clinical isolates of S. aureus were identified from different patients. The prevalence of methicillin resistance among S. aureus isolates was 8.7% (28 isolates). Resistance rates of MRSA to other antibiotics were as follows: 82.1% resistant to erythromycin, 67.9% to clindamycin, 64.3% to gentamicin, and 32.1% to ciprofloxacin. No co-trimoxazole- and vancomycin-resistant isolates were identified in this study. The proportion of methicillin resistance was highest among S. aureus isolates associated with upper respiratory specimens (42.8%); the proportion of methicillin resistance was 39.3% among skin ulcer isolates, 10.7% among urinary tract infection isolates, and lowest among isolates associated with blood and prostate discharge (3.6% each).

AttachmentSize
Nosocomial infection caused by methicillin-resistant Staphylococcus aureus in Palestine.pdf23.56 KB